Table 9.

Results of paclitaxel nanoformulations with different concentrations of mannitol after freeze drying.

Code	Formulations			Blank			2 % Mannitol			5 % Mannitol			10 % Mannitol
	PS(nm)	PDI	ZP(mv)	PS(nm)	PDI	ZP(mv)	PS(nm)	PDI	ZP(mv)	PS(nm)	PDI	ZP(mv)	PS(nm)	PDI	ZP(mv)
PTX 84	190 ± 12.42	0.13 ± 0.02	−30 ± 1.1	237 ± 1.15	0.19 ± 0.01	−24.3 ± 2.2	244 ± 13.2	0.2 ± 0.08	−31.1 ± 1.5	185 ± 2.8	0.1 ± 0.2	−31.2 ± 1.2	298 ± 9.1	0.35 ± 1.8	−24.4 ± 1.1
PTX 86	287 ± 13.51	0.2 ± 0.01	−35.8 ± 1.2	329 ± 15.5	0.3 ± 0.1	−34.3 ± 1.5	350 ± 1.9	0.19 ± 0.03	−30 ± 2.5	293 ± 17.2	0.18 ± 1.2	−36.4 ± 2.9	377 ± 6.9	0.4 ± 1.2	−29.7 ± 1.1
PTX 108	202 ± 14.5	0.17 ± 0.03	−35.2 ± 0.1	293 ± 12.3	0.2 ± 0.15	−29.0 ± 2.3	280 ± 2.4	0.23 ± 0.02	–33.4 ± 1.4	190 ± 14.1	0.2 ± 0.11	−35.1 ± 1.3	356 ± 17.3	0.2 ± 1.2	−34.3 ± 1.2
PTX 112	229 ± 13.24	0.2 ± 0.01	−40.4 ± 1.6	312 ± 6.09	0.4 ± 0.11	−38.4 ± 1.7	305 ± 3.31	0.24 ± 0.02	−36.9 ± 1	211 ± 3.1	0.2 ± 0.9	−38.9 ± 2.9	308 ± 24.3	0.5 ± 1.3	−29.1 ± 2.4